Details

Genetic background of macular telangiectasia type 2
ID Kunčič, Ajda (Author), ID Baloh-Urbančič, Mojca (Author), ID Dobovšek Divjak, Darja (Author), ID Hudler, Petra (Author), ID Debeljak, Nataša (Author)

.pdfPDF - Presentation file, Download (2,14 MB)
MD5: C3B3D78A57E93BFDEA88B3B4D4255502
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/26/2/684 This link opens in a new window

Abstract
Macular telangiectasia type 2 (MacTel) is a slowly progressive macular disorder that is often diagnosed late due to the gradual onset of vision loss. Recent advances in diagnostic techniques have facilitated earlier detection and have shown that MacTel is more common than initially thought. The disease is genetically complex, and multiple variants contribute incrementally to the overall risk. The familial occurrence of the disease prompted the investigation of the genetic background of MacTel. To better understand the molecular milieu of the disease, a literature review of the clinical reports and publications investigating the genetic factors of MacTel was performed. To date, disease-associated variants have been found in genes involved in amino acid (glycine/serine) metabolism and transport, urea cycle, lipid metabolism, and retinal vasculature and thickness. Variants in genes implicated in sphingolipid metabolism and fatty acid/steroid/retinol metabolism have been found in patients with neurological disorders who also have MacTel. Retinal metabolism involves complex biochemical processes that are essential for maintaining the high energy requirements of the retina. Genetic alterations can disrupt key metabolic pathways, leading to retinal cell degradation and the subsequent vision loss that characterizes several retinal disorders, including MacTel. This review article summarizes genetic findings that may allow MacTel to be further investigated as an inherited retinal disorder.

Language:English
Keywords:retina, macular disorder, macular telangiectasia type 2, MacTel, complex disease, genetic predisposition, genomic biomarkers
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:19 str.
Numbering:Vol. 26, iss. 2, art. 684
PID:20.500.12556/RUL-166771 This link opens in a new window
UDC:617.7
ISSN on article:1422-0067
DOI:10.3390/ijms26020684 This link opens in a new window
COBISS.SI-ID:223746819 This link opens in a new window
Publication date in RUL:24.01.2025
Views:790
Downloads:964
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:mrežnica, makularna motnja, makularna telangiektazija tipa 2, Mac Tel, kompleksna bolezen, genetska predispozicija, genomski biološki označevalci

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0390
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young researchers

Funder:University Medical Centre Ljubljana
Funding programme:Tertiary Research and Development Project
Project number:20230137

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back